Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine

ClinicalTrials.gov ID: NCT02638103

Public ClinicalTrials.gov record NCT02638103. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous (SC) administration of TEV-48125 in adult participants with chronic migraine (CM) or episodic migraine (EM). Participants with CM or EM who complete the pivotal efficacy studies of TEV-48125 (TV48125-CNS-30049 \[NCT02621931\] and TV48125-CNS-30050 \[NCT02629861\]) and agree to participate in this study; and new participants meeting eligibility criteria (not rolling over from pivotal studies), will be enrolled in this study.

Study identification

NCT ID
NCT02638103
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,890 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 25, 2016
Primary completion
Jun 5, 2018
Completion
Dec 7, 2018
Last update posted
Nov 8, 2021

2016 – 2018

United States locations

U.S. sites
90
U.S. states
37
U.S. cities
78
Facility City State ZIP Site status
Teva Investigational Site 13628 Birmingham Alabama 35211
Teva Investigational Site 13577 Birmingham Alabama 35216
Teva Investigational Site 13606 Phoenix Arizona 85018
Teva Investigational Site 13579 Phoenix Arizona 85023
Teva Investigational Site 13602 Little Rock Arkansas 72205
Teva Investigational Site 13568 Encino California 91316
Teva Investigational Site 13546 Fullerton California 92835
Teva Investigational Site 13540 Long Beach California 90806
Teva Investigational Site 13632 Redlands California 92374
Teva Investigational Site 13571 Redondo Beach California 90277
Teva Investigational Site 13573 San Diego California 92103
Teva Investigational Site 13538 Santa Monica California 90404
Teva Investigational Site 13594 Santa Rosa California 95405
Teva Investigational Site 13595 Walnut Creek California 94598
Teva Investigational Site 13629 Aurora Colorado 80014
Teva Investigational Site 13557 Boulder Colorado 80301
Teva Investigational Site 13593 Colorado Springs Colorado 80918
Teva Investigational Site 13633 Denver Colorado 80210
Teva Investigational Site 13612 Denver Colorado 80239
Teva Investigational Site 13631 Englewood Colorado 80113
Teva Investigational Site 13563 East Hartford Connecticut 06118
Teva Investigational Site 13550 Stamford Connecticut 06905
Teva Investigational Site 13635 Bradenton Florida 34201
Teva Investigational Site 13597 Gainesville Florida 32607
Teva Investigational Site 13607 Hialeah Florida 33012
Teva Investigational Site 13559 Jacksonville Florida 32205
Teva Investigational Site 13584 Ocala Florida 34471
Teva Investigational Site 13587 Orlando Florida 32806
Teva Investigational Site 13567 Palm Beach Gardens Florida 33410
Teva Investigational Site 13553 Pembroke Pines Florida 33026
Teva Investigational Site 13616 Pinellas Park Florida 33781
Teva Investigational Site 13620 Atlanta Georgia 30312
Teva Investigational Site 13537 Atlanta Georgia 30342
Teva Investigational Site 13604 Boise Idaho 83642
Teva Investigational Site 13585 Chicago Illinois 60607
Teva Investigational Site 13621 Chicago Illinois 60654
Teva Investigational Site 13627 Evanston Illinois 60201
Teva Investigational Site 13596 Indianapolis Indiana 46254
Teva Investigational Site 13617 Wichita Kansas 67207
Teva Investigational Site 13598 Wichita Kansas 67211
Teva Investigational Site 13566 Louisville Kentucky 40207
Teva Investigational Site 13603 Metairie Louisiana 70006
Teva Investigational Site 13582 Pikesville Maryland 21208
Teva Investigational Site 13590 Boston Massachusetts 02131
Teva Investigational Site 13589 New Bedford Massachusetts 02301
Teva Investigational Site 13543 Watertown Massachusetts 02472
Teva Investigational Site 13539 Ann Arbor Michigan 48104
Teva Investigational Site 13542 Golden Valley Minnesota 55422
Teva Investigational Site 13534 Kansas City Missouri 64114
Teva Investigational Site 13536 Springfield Missouri 65807
Teva Investigational Site 13619 St Louis Missouri 63141
Teva Investigational Site 13618 Fremont Nebraska 68025
Teva Investigational Site 13605 Las Vegas Nevada 89106
Teva Investigational Site 13578 Lebanon New Hampshire 03756
Teva Investigational Site 13575 Martinsville New Jersey 08836
Teva Investigational Site 13622 Princeton New Jersey 08540
Teva Investigational Site 13588 Albuquerque New Mexico 87102
Teva Investigational Site 13576 Amherst New York 14226
Teva Investigational Site 13565 Plainview New York 11803
Teva Investigational Site 13544 Greensboro North Carolina 27405
Teva Investigational Site 13574 Greensboro North Carolina 27408
Teva Investigational Site 13545 Raleigh North Carolina 27612
Teva Investigational Site 13609 Akron Ohio 44311
Teva Investigational Site 13625 Akron Ohio 44311
Teva Investigational Site 13634 Akron Ohio 44311
Teva Investigational Site 13533 Cincinnati Ohio 45227
Teva Investigational Site 13624 Cincinnati Ohio 45249
Teva Investigational Site 13569 Cleveland Ohio 44195
Teva Investigational Site 13626 Columbus Ohio 43212
Teva Investigational Site 13561 Oklahoma City Oklahoma 73112
Teva Investigational Site 13601 Eugene Oregon 97401
Teva Investigational Site 13591 Jenkintown Pennsylvania 19046
Teva Investigational Site 13554 Philadelphia Pennsylvania 19107
Teva Investigational Site 13608 Uniontown Pennsylvania 15401
Teva Investigational Site 13615 Greer South Carolina 29650
Teva Investigational Site 13556 Mt. Pleasant South Carolina 29464
Teva Investigational Site 13560 Bristol Tennessee 37620
Teva Investigational Site 13551 Memphis Tennessee 38119
Teva Investigational Site 13532 Nashville Tennessee 37203
Teva Investigational Site 13552 Nashville Tennessee 37203
Teva Investigational Site 13541 Austin Texas 78731
Teva Investigational Site 13623 Dallas Texas 75214
Teva Investigational Site 13611 Plano Texas 75024
Teva Investigational Site 13572 San Antonio Texas 78229
Teva Investigational Site 13614 Murray Utah 84107
Teva Investigational Site 13581 West Jordan Utah 84088
Teva Investigational Site 13630 Virginia Beach Virginia 23454
Teva Investigational Site 13564 Seattle Washington 98105
Teva Investigational Site 13586 Seattle Washington 98105
Teva Investigational Site 13600 Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02638103, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 8, 2021 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02638103 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →